Inactive Instrument
Bellicum Pharmaceuticals, Inc. Stock OTC Markets
Stocks
BLCM
US0794814048
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -6.68% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dave Maggio
CEO | Chief Executive Officer | 66 | 2024-02-22 |
Richard Fair
CEO | Chief Executive Officer | 57 | 2017-01-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Fair
BRD | Director/Board Member | 57 | - |
Judith Kilmovsky
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.68% | -18.17% | - | - | 822K | |
| -3.00% | +2.27% | +77.60% | +109.33% | 72.12B | |
| +1.90% | +23.53% | +56.60% | +97.76% | 65.85B | |
| +5.12% | +25.22% | +5.24% | -0.82% | 29.28B | |
| +0.55% | +1.64% | -5.15% | +471.68% | 27.47B | |
| +2.74% | +12.98% | +62.84% | +28.14% | 26.7B | |
| +0.47% | +6.12% | +36.66% | -13.79% | 20.06B | |
| +1.82% | -6.67% | +247.46% | +393.10% | 18.22B | |
| +0.94% | +3.36% | +18.55% | +532.94% | 16.4B | |
| +0.73% | +5.54% | +39.71% | +153.07% | 13.4B | |
| Average | +0.46% | +8.36% | +59.94% | +196.82% | 32.17B | |
| Weighted average by Cap. | +0.74% | +9.48% | +59.05% | +157.80% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 6.2M 5.31M 4.97M 4.55M 8.54M 593M 8.65M 58.71M 22.9M 298M 23.28M 22.77M 986M | 1.5M 1.28M 1.2M 1.1M 2.07M 144M 2.09M 14.2M 5.54M 72.1M 5.63M 5.51M 238M |
| Net income | -9.7M -8.31M -7.78M -7.12M -13.36M -929M -13.54M -91.9M -35.84M -466M -36.44M -35.65M -1.54B | -24.97M -21.39M -20.02M -18.32M -34.39M -2.39B -34.84M -236M -92.22M -1.2B -93.77M -91.73M -3.97B |
| Net Debt | - | - |
Employees
13
